The suit seeking a jury trial to determine whether Pfizer is liable in Carter Albrecht’s death was prepared by Barrett Stetson and Thomas Moynihan. A quick read-through of the 36-page document gives me the impression that they did their homework on the science and marketing of the smoking-cessation drug Chantix. The fact that Pfizer has already changed its label to warn about serious neuropsychiatric side effects wouldn’t seem to bode well for the drug maker. But it’s easy to see the tack the defense would take if this ever went to trial: Albrecht was drunk the night he was shot while banging on his neighbor’s door, and the coroner couldn’t say that Albrecht even had Chantix in his system that night — because only Pfizer knows how to test for the drug.
Related Articles
Travel
Is Fort Worth Really ‘The New Austin’?
The Times of London tells us it's now the coolest city in Texas.
By Tim Rogers
Dallas 500
Meet the Dallas 500: Chakri Gottemukkala, o9 Solutions
The o9 solutions leader talks about garnering a $3.7 billion valuation, growing 10x over the next few years, and how the company is innovating.
By D CEO Staff
Local News
An Early Look at 2026 FIFA World Cup Logistics
The World Cup matches will be held in Arlington, but Dallas will be home to a great deal of team and fan experiences. We're getting an early look at what that will look like.